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Most  of head  and  neck  Leiomyosarcoma  present  with primary  lesion  in  skin  and  soft  tissue,  minority  are
found  in mucosal  sites,  Leiomyosarcoma  is  derived  from  vascular  smooth  muscles  or arrector  pili muscles
of  hair  follicles,  intraoral  presentation  is extremely  rare  of  which  tongue  appears  to  be most  common
intraoral  site  followed  by  palate.
We present  a  case  report  of  large  (4.5  cm  ×  5.5 cm  ×  3.5  cm)  Leiomyosarcoma  of  retromolar  trigone.
A  68  years  old  male  patient  presented  with  a history  of  painless  lump  in the  oral  cavity  since  a  period  of 4
months.  Clinical  examination  revealed  a large  nodular  growth  in  the  left  retro  molar  trigone.  Radiological
features  suggested  lingual  and  buccal  extension  of  the  lesion  with  destruction  of mandible.  Incision  biopsy
was  suggestive  of spindle  cell  tumour.  Metastatic  work  up  was  negative  for metastasis,  following  which
patient  was  treated  by  surgical  resection  and  reconstruction.
Final histology  was suggestive  of high  grade  leiomyosarcoma  based  on  morphological  ﬁndings  and
panel  of  IHC  reports.  Patient  was further  managed  with  post  operative  adjuvant  radiotherapy  and  is
under  follow  up  since  a period  of  6 months.
©  2014  Japanese  Stomatological  Society.  Published  by  Elsevier  Ltd. All rights  reserved.. Introduction
Soft tissue sarcomas are rare neoplasms with only 1% of them
resenting in the head and neck region [1]. Leiomyosarcoma rep-
esents 1–4% of those tumors [2–4] mostly affecting middle-aged
dults or the elderly [5]. It is derived from the smooth muscle; the
carcity of the smooth muscle in the head and neck region might
xplain the infrequency of its occurrence in these sites. Eighty-three
ercent of head and neck leiomyosarcoma cases present as primary
esions in the skin and soft tissues; they present less often in sali-
ary glands [6] and very rarely in an intraoral site. This tumor is
erived from cutaneous (arrector pili muscles of hair follicles) or
ubcutaneous (vascular smooth muscle) tissues. In intraoral pre-
entation, probably it may  originate from vascular smooth muscle,
yoepithelial cells, or undifferentiated mesenchymal cells.
The  common intraoral sites described in literature include
he tongue, palate, maxilla, mandible, and, less often, the buccal
ucosa; they are infrequently reported at the retromolar trigone
∗ Corresponding author. Tel.: +91 9963306663; fax: +91 4066881947.
E-mail addresses: sandhyagokavarapu@gmail.com (S. Gokavarapu),
eevan1983@yahoo.com (K.A. Jeevan Kumar), rcveligeti@yahoo.com (R. Chander),
umurthy@gmail.com (S. Murthy).
ttp://dx.doi.org/10.1016/S1348-8643(14)00006-8
348-8643/© 2014 Japanese Stomatological Society. Published by Elsevier Ltd. All rights [7]. Most of the reported tumors are <5 cm in size [5]. The cur-
rent case is rare for the location of its presentation as well as the
size.
2. Case report
A  68-year-old male patient presented with a history of pain-
less lump in the oral cavity (Fig. 1). In a period of 4 months, the
patient observed a rapid increase in the size of the tumor and
presented for treatment and management at the surgical outpa-
tient department (OPD). Clinical examination revealed a nodular
growth in the left retromolar trigone with an extension of the lesion
along gingivolingual and gingivobuccal sulcus. Radiological fea-
tures revealed destruction of body and angle of the mandible with
large, enhancing soft-tissue component in the sublingual space,
measuring approximately 5.3 cm × 2 cm;  the soft-tissue compo-
nent in the buccal space measured 4.2 cm × 2.5 cm with destruction
of the inner cortex of the mandible (Figs. 2 and 3). Incision biopsy
was suggestive of spindle cell tumor. There was no evidence of
distant metastasis on the posterior–anterior chest radiograph or
ultrasound of the abdomen. The patient was to undergo surgical
resection of the tumor.
Surgical  resection involved sectioning of the mandible mesial
to the ﬁrst premolar with >1 cm of soft- and hard-tissue margin
reserved.
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Fig. 1. Clinical picture of the tumor illustrating the intraoral presentation of the
lesion.
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ig. 2. Radiological ﬁndings (CT scan) of the axial section: soft-tissue mass encircling the 
he  lingual aspect of the mandible.
Fig. 3. Radiological ﬁndings (CT scan) of the sagittal section:ternational 11 (2014) 76–79 77
around the tumor (Fig. 4). Selective lymph nodal clearance of level
I to level III was done. The defect was  reconstructed with pectoralis
major myocutaneous ﬂap. Postoperative partial ﬂap necrosis was
observed on the 15th day; however, healing was  uneventful fol-
lowing the revision of the necrosed component. The patient also
underwent adjuvant radiotherapy.
On  gross examination, the tumor measured 4.5 cm ×
5.5  cm × 3.5 cm with the tissue encircling the mandible. The
margins were clear with a minimum of 1-cm overall clearance
(Fig. 4).
Hematoxylin and eosin (H&E) sections revealed fascicles and
bundles of spindle-shaped cells with elongated dark nuclei, inter-
spersed branching vessels, and frequent mitoses (Figs. 5 and 6); a
morphological diagnosis of spindle cell neoplasm was  made. Pan-
els of immunohistochemical (IHC) stains were used to deﬁne the
same. IHC stains were strongly positive for smooth muscle actin
(SMA) in a majority of cells (Fig. 7), while Ki-67 was 60%. How-
ever, tumor cells were negative for CD31 and CD34, Desmin, S100,
and Pancytokeratin. A diagnosis of “high-grade leiomyosarcoma”
was made based upon overall ﬁndings. None of the excised cervical
lymph nodes showed evidence of nodal metastasis; however, they
showed inﬂammatory hyperplasia.
body of mandible involving buccal and lingual spaces, bone destruction is noted on
 soft-tissue mass encircling the body of the mandible.
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Fig. 6. H&E-stained slide of the tumor in 40× magniﬁcation; fascicles and bundlesig. 4. Surgical resection specimen: gross appearance of the entire tumor with buc-
al and lingual components can be illustrated.
. Discussion
Oral leiomyosarcomas may  originate in sites of high vascu-
arity corresponding to high incidence in the palate and tongue,
elative to other oral sites. Intrabony presentations arising from
orresponding vessels are reported with higher frequency as well
5]. The current case is unique and rare owing to the site of clin-
cal presentation at retromolar trigone and numbers associated
ith such presentation. Histopathological diagnosis of this tumor
ig. 5. H&E-stained slide of the tumor in 10× magniﬁcation: fascicles and bundles
f  spindle-shaped cells with elongated dark nuclei, interspersed branching vessels,
nd frequent mitoses can be noted.of  spindle-shaped cells with elongated dark nuclei, interspersed branching vessels,
and frequent mitoses along with marked nuclear pleomorphism is seen.
is difﬁcult. Differential diagnosis includes ﬁbrosarcoma, myoﬁ-
brosarcoma, synovial sarcoma, malignant peripheral nerve sheath
tumor, solitary neuroﬁbroma, rhabdomyosarcoma, liposarcoma,
and malignant ﬁbrous histiocytoma. Accurate diagnosis through
a routine histopathology study is debatable [8]. The prognosis,
treatment, and management vary for these tumors. IHC or elec-
tron microscopy is an accepted method to conﬁrm diagnosis.
Immunopositivity for vimentin, SMA, and muscle-speciﬁc actin
(MSA) is attributed to leiomyosarcoma [9]. A clinicopathological
and IHC study by Nicolas et al. [10] suggested SMA  positivity in
100% of their tumors; these authors suggested that the classical
leiomyosarcoma component was positive for at least one myo-
genic IHC marker. The presented tumor showed positivity for SMA
but negativity for CD31, CD34, Desmin, S100, and PCK. Consid-
ering exclusion of other related tumors and strong positivity for
SMA with 60% of Ki-67 values, diagnosis of “high-grade leiomyosar-
coma” was  made.
Currently,  surgery is the best option for effective treatment and
resection with adequate margin is essential [6]. Evidence showed
occasional occurrence of lymph nodal metastasis among head and
neck leiomyosarcomas [6]; thus, regional lymphatic clearance in
relation to risk factors such as the grade and T stage may  be consid-
ered. Selective neck dissection was  performed in this patient based
on these factors [6].
Fig. 7. IHC for smooth muscle actin: strong positivity for smooth muscle actin in
majority of cells can be illustrated.
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cases. Hum Pathol 2010;41:663–71.S. Gokavarapu et al. / Oral Sci
A population-based analysis by Eppsteiner et al. [6] indicated
hat only 13% patients present with leiomyosarcoma of size greater
han 5 cm among head and neck sites; 40% of the tumors are
oorly differentiated. Further, patients treated with surgery alone
ad better outcome. The size of the tumor in the present case
easured 4.5 cm × 5.5 cm × 3.5 cm,  again showing the rarity of
he current case. Adjuvant radiotherapy was reserved for patients
ith poor prognostic factors with large size and high-grade can-
er.
In leiomyosarcoma, though chemotherapy is not effective,
itsudo et al. [11] showed promising results in patients with inop-
rable tumors in palliative situation as a neo-adjuvant option in
rial sitting. These authors showed that the treatment of maxillary
eiomyosarcoma with super selective intra-arterial chemotherapy
ia a superﬁcial temporal artery using docetaxel (DOC) and cisplatin
CDDP) resulted in tumor shrinkage to 50% of original dimensions,
ith 80% of degeneration and necrosis of tumor cells occurring in
he surgical resection specimen. Follow-up of 2 years in this patient
as uneventful [11]. Further research is necessary to optimize this
ethod; however, in a palliative situation, such a method may  be
 good option.
Prognosis of leiomyosarcoma depends on the grade of the
umor; 5-year survival was 87.6% in cases with well-differentiated
umors, whereas 5-year survival for poorly differentiated tumors
as 52.7% [6].
Considering the high-grade status and size greater than
 cm,  both poor prognostic factors, adequate care was taken
n the management of this patient. Tumor-free adequate mar-
ins were obtained with regional lymph nodal sampling;
djuvant radiotherapy was given. Patient did not consent for
ree tissue transfer and hence osseous reconstruction was  not
onsidered. Currently, patient is under close follow-up since
 months.
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